ArticleTransplant infectious disease : an official journal of the Transplantation Society2020
Hyperammonemia syndrome due to Ureaplasma infection after liver-kidney transplant.
Article in Transplant infectious disease : an official journal of the Transplantation Society, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
12 citing papers in PubMed, 1 synthesis or guideline pooled it, 19 citations in OpenAlex.
- Hyperammonemia After Lung Transplantation: Systematic Review and a Mini Case Series.Transplant international : official journal of the European Society for Organ Transplantation · 2022Pooled it
- Hyperammonemia syndrome in a liver transplant recipient due toJournal of surgical case reports · 2026Article
- Article
- Review
- A late-onset hyperammonemia syndrome caused byHeliyon · 2024Article
- Disseminated Ureaplasma infection: A case report of septic polyarthritis in a patient on Rituximab therapy.IDCases · 2024Article
- Article
- Hyperammonaemia syndrome in disseminatedBMJ case reports · 2022Article
- Article
- A novel cause of emergent hyperammonemia:Molecular genetics and metabolism reports · 2021Article
- Impact of Screening and Treatment of Ureaplasma species on Hyperammonemia Syndrome in Lung Transplant Recipients: A Single Center Experience.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America · 2021Article
- Lethal hyperammonemia in a CAR-T cell recipient due toBMJ case reports · 2021Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
13 authors at 1 institution in 1 country.
Funding
Abstract
Hyperammonemia syndrome, with high levels of ammonia and neurologic dysfunction, is a syndrome with historically high mortality that may occur after solid organ transplantation. Recently, this has been associated with infection due to Ureaplasma, mostly following lung transplantation. We describe the first case of hyperammonemia syndrome due to Ureaplasma infection after liver-kidney transplantation. Our patient rapidly recovered after specific antibiotic treatment. It is important to consider these infections in the differential diagnosis for encephalopathy post-transplant, as these organisms often do not grow using routine culture methods and polymerase chain reaction testing is typically required for their detection. This is particularly critical after liver transplantation, where a number of other etiologies may be considered as a cause of hyperammonemia syndrome.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.